Furthermore, the proportion of PD1+/CD8+ T cells in the tumor microenvironment (TME) was markedly higher compared to PBMC (88.54% vs. 31.48%, p < 0.0001), indicating an activated tumor immune environment. This evidence concerns the gene CD8A and neoplasm.